S. Charleson

5.6k total citations
51 papers, 2.7k citations indexed

About

S. Charleson is a scholar working on Physiology, Pharmacology and Organic Chemistry. According to data from OpenAlex, S. Charleson has authored 51 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 16 papers in Pharmacology and 13 papers in Organic Chemistry. Recurrent topics in S. Charleson's work include Asthma and respiratory diseases (22 papers), Inflammatory mediators and NSAID effects (14 papers) and Synthesis and biological activity (9 papers). S. Charleson is often cited by papers focused on Asthma and respiratory diseases (22 papers), Inflammatory mediators and NSAID effects (14 papers) and Synthesis and biological activity (9 papers). S. Charleson collaborates with scholars based in Canada, United States and Denmark. S. Charleson's co-authors include Joseph A. Mancini, Denis Riendeau, Elizabeth Wong, Philip J. Vickers, Diane Ethier, Jillian F. Evans, A. W. Ford‐Hutchinson, Paul L. Wood, Roger L. Hudgin and Stacia Kargman and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

S. Charleson

50 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S. Charleson 1.0k 791 770 505 339 51 2.7k
Danielle Denis 825 0.8× 451 0.6× 597 0.8× 478 0.9× 282 0.8× 37 2.0k
F. A. Kuehl 1.6k 1.6× 801 1.0× 1.1k 1.4× 315 0.6× 881 2.6× 39 3.8k
Hans‐Erik Claesson 726 0.7× 1.0k 1.3× 1.2k 1.6× 223 0.4× 527 1.6× 109 3.6k
Geoffrey J. Blackwell 1.2k 1.2× 684 0.9× 1.2k 1.5× 107 0.2× 618 1.8× 30 3.5k
A Raz 1.5k 1.4× 359 0.5× 593 0.8× 244 0.5× 655 1.9× 32 2.6k
Barry M. Weichman 369 0.4× 722 0.9× 640 0.8× 177 0.4× 141 0.4× 68 2.1k
N. K. Boughton-Smith 521 0.5× 1.3k 1.6× 483 0.6× 118 0.2× 548 1.6× 40 2.9k
K.E. Eakins 1.3k 1.2× 408 0.5× 597 0.8× 132 0.3× 398 1.2× 55 2.8k
F.F. Sun 777 0.8× 459 0.6× 520 0.7× 153 0.3× 568 1.7× 48 2.0k
Joseph Chang 444 0.4× 342 0.4× 905 1.2× 194 0.4× 185 0.5× 73 2.4k

Countries citing papers authored by S. Charleson

Since Specialization
Citations

This map shows the geographic impact of S. Charleson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Charleson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Charleson more than expected).

Fields of papers citing papers by S. Charleson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Charleson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Charleson. The network helps show where S. Charleson may publish in the future.

Co-authorship network of co-authors of S. Charleson

This figure shows the co-authorship network connecting the top 25 collaborators of S. Charleson. A scholar is included among the top collaborators of S. Charleson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Charleson. S. Charleson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deschênes, Denis, Daniel Dubé, Michel Gallant, et al.. (2006). Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(10). 2608–2612. 3 indexed citations
2.
Li, Chun Sing, Christine Brideau, Chi Chung Chan, et al.. (2003). Pyridazinones as selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(4). 597–600. 67 indexed citations
3.
Black, W. Cameron, Christine Brideau, Chi-Chung Chan, et al.. (2003). 3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 13(6). 1195–1198. 29 indexed citations
4.
Ouimet, Nathalie, Chi-Chung Chan, S. Charleson, et al.. (1999). Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class. Bioorganic & Medicinal Chemistry Letters. 9(2). 151–156. 20 indexed citations
5.
Frenette, Richard, John H. Hutchinson, Serge Léger, et al.. (1999). Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(16). 2391–2396. 11 indexed citations
6.
Black, W. Cameron, Christine Brideau, S. Charleson, et al.. (1999). A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(22). 3181–3186. 23 indexed citations
7.
Lau, Cheuk K., Christine Brideau, Chi Chung Chan, et al.. (1999). Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(22). 3187–3192. 25 indexed citations
8.
LEBLANC, Y., Patrick Roy, S. Boyce, et al.. (1999). SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor. Bioorganic & Medicinal Chemistry Letters. 9(15). 2207–2212. 38 indexed citations
9.
Friesen, Richard W., Christine Brideau, Chi Chung Chan, et al.. (1998). 2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(19). 2777–2782. 111 indexed citations
10.
Wong, Elizabeth, Carmela DeLuca, S. Charleson, et al.. (1997). Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells. Inflammation Research. 46(2). 51–59. 34 indexed citations
11.
Hutchinson, John H., S. Charleson, Jillian F. Evans, et al.. (1995). Thiopyranol[2,3,4-c,d]indoles as Inhibitors of 5-Lipoxygenase, 5-Lipoxygenase-Activating Protein, and Leukotriene C4 Synthase. Journal of Medicinal Chemistry. 38(22). 4538–4547. 34 indexed citations
12.
Mancini, Joseph A., et al.. (1994). The binding of leukotriene biosynthesis inhibitors to site-directed mutants of human 5-lipoxygenase-activating protein. Life Sciences. 54(9). PL137–PL142. 13 indexed citations
13.
Charleson, S., Jilly F. Evans, Serge Léger, et al.. (1994). Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein. European Journal of Pharmacology Molecular Pharmacology. 267(3). 275–280. 22 indexed citations
14.
Prasit, Peppi, Michel Belley, Christine Brideau, et al.. (1993). A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.. PubMed. 6(1-3). 239–44. 21 indexed citations
15.
Woods, John, Jilly F. Evans, Diane Ethier, et al.. (1993). 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.. The Journal of Experimental Medicine. 178(6). 1935–1946. 341 indexed citations
16.
Mancini, Joseph A., Mark Abramovitz, Martha E. Cox, et al.. (1993). 5‐lipoxygenase‐activating protein is an arachidonate binding protein. FEBS Letters. 318(3). 277–281. 179 indexed citations
17.
Charleson, S., Petpiboon Prasit, Serge Léger, et al.. (1992). Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition.. Molecular Pharmacology. 41(5). 873–879. 32 indexed citations
18.
Rokach, Joshua, Malo Jl, Diane Ethier, et al.. (1990). Urinary leukotriene E4 levels during early and late asthmatic responses. Journal of Allergy and Clinical Immunology. 86(2). 211–220. 158 indexed citations
19.
Nicoll‐Griffith, Deborah A., et al.. (1990). BIO-fully automated sample treatment high-performance liquid chromatography and radioimmunoassay for leukotriene E4 in human urine from asthmatics. Journal of Chromatography B Biomedical Sciences and Applications. 526(2). 341–354. 14 indexed citations
20.
Garceau, D., Anthony W. Ford‐Hutchinson, & S. Charleson. (1987). 5-Lipoxygenase inhibitors and allergic conjunctivitis reactions in the guinea-pig. European Journal of Pharmacology. 143(1). 1–7. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle Denis Breakdown of academic impact, for papers by F. A. Kuehl Breakdown of academic impact, for papers by Hans‐Erik Claesson Breakdown of academic impact, for papers by Geoffrey J. Blackwell Breakdown of academic impact, for papers by A Raz Breakdown of academic impact, for papers by Barry M. Weichman Breakdown of academic impact, for papers by N. K. Boughton-Smith Breakdown of academic impact, for papers by K.E. Eakins Breakdown of academic impact, for papers by F.F. Sun Breakdown of academic impact, for papers by Joseph Chang
Rankless by CCL
2026